Publication
Lifetime attributable cancer risk assessment in pediatric patients undergoing I-124 PET for differentiated thyroid cancer.
Amirhossein Maddahi, Roghiye Bodaghi Hosseinabadi, Asra Sadat Talebi
Radiation protection dosimetrySep 8, 2026PMID 42709686doi:10.1093/rpd/ncag107 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
The increasing use of I-124 PET for differentiated thyroid cancer (DTC) has raised concerns about radiation exposure in pediatric patients because of their radiosensitivity. This study estimated organ-absorbed doses and the lifetime attributable risk (LAR) of secondary cancer following I-124 PET…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Thyroid Gland Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.